RNA editing-based biomarker blood test for the diagnosis of bipolar disorder: protocol of the EDIT-B study

Misdiagnosis of bipolar disorder (BD) can lead to ineffective treatment, increased risk of manic episodes, and increased severity. Objective diagnostic tests or precise tools to diagnose BD and distinguish it from major depressive disorder (MDD) in depressed patients are lacking.

Publication Details

Journal
Universität Zürich, ZORA
Published
2025-02-06
DOI
https://doi.org/10.5167/uzh-280919
Primary Topic
Bipolar Disorder and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RNA editing-based biomarker blood test for the diagnosis of bipolar disorder: protocol of the EDIT-B study

Universität Zürich, ZORA
Bipolar Disorder and Treatment
article

RNA editing-based biomarker blood test for the diagnosis of bipolar disorder: protocol of the EDIT-B study

article en

Abstract

Misdiagnosis of bipolar disorder (BD) can lead to ineffective treatment, increased risk of manic episodes, and increased severity. Objective diagnostic tests or precise tools to diagnose BD and distinguish it from major depressive disorder (MDD) in depressed patients are lacking.

Universität Zürich, ZORA
Good health and well-being
Openalex Percentile: Top 39%
Bipolar Disorder and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

RNA editing-based biomarker blood test for the diagnosis of bipolar disorder: protocol of the EDIT-B study · Universität Zürich, ZORA (2025) | TGRS Research Map | TGRS